Commentary: Different immunological mechanisms govern protection from experimental stroke in young and older mice with recombinant TCR ligand therapy

Keith R. Pennypacker

doi:10.3389/fncel.2014.00339

Commentary: Different immunological mechanisms govern protection from experimental stroke in young and older mice with recombinant TCR ligand therapy

Research output: Contribution to journal › Comment/debate

4 Scopus citations

Original language	English
Article number	339
Journal	Frontiers in Cellular Neuroscience
Volume	8
Issue number	OCT
DOIs	https://doi.org/10.3389/fncel.2014.00339
State	Published - Oct 17 2014

Keywords

Aging
Experimental stroke
Immune response
Neuroinflammation
RTL1000
Therapy

ASJC Scopus subject areas

Cellular and Molecular Neuroscience

Access to Document

10.3389/fncel.2014.00339

Cite this

@article{21bb385d10804a65b671f86f159f1c70,

title = "Commentary: Different immunological mechanisms govern protection from experimental stroke in young and older mice with recombinant TCR ligand therapy",

keywords = "Aging, Experimental stroke, Immune response, Neuroinflammation, RTL1000, Therapy",

author = "Pennypacker, {Keith R.}",

year = "2014",

month = oct,

day = "17",

doi = "10.3389/fncel.2014.00339",

language = "English",

volume = "8",

number = "OCT",

}

TY - JOUR

T1 - Commentary

T2 - Different immunological mechanisms govern protection from experimental stroke in young and older mice with recombinant TCR ligand therapy

AU - Pennypacker, Keith R.

PY - 2014/10/17

Y1 - 2014/10/17

KW - Aging

KW - Experimental stroke

KW - Immune response

KW - Neuroinflammation

KW - RTL1000

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=84907986728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907986728&partnerID=8YFLogxK

U2 - 10.3389/fncel.2014.00339

DO - 10.3389/fncel.2014.00339

M3 - Comment/debate

AN - SCOPUS:84907986728

SN - 1662-5102

VL - 8

JO - Frontiers in Cellular Neuroscience

JF - Frontiers in Cellular Neuroscience

IS - OCT

M1 - 339

ER -

Commentary: Different immunological mechanisms govern protection from experimental stroke in young and older mice with recombinant TCR ligand therapy

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this